Boston Omaha Corp (NASDAQ:BOMN), a significant shareholder in Sky Harbour Group Corp (NYSE:SKYH), has reported selling shares worth $192,962 over a three-day period. The transactions, disclosed in a ...

Garvey, a director at PhenixFIN Corp (NASDAQ:PFX), recently purchased 500 shares of the company's common stock, according to a recent SEC filing. The shares were acquired at a weighted average price ...

SAN DIEGO, CA – Daré Bioscience, Inc., a biopharmaceutical company with a current market capitalization of $26.45 million and trading at $3.04 per share, is facing potential delisting from the Nasdaq ...

DevvStream Corp., a company listed under the investors sector with a market capitalization of $12.73 million, has been notified by The Nasdaq Stock Market LLC of a potential delisting due to its share ...

Solidion Technology Inc. (NASDAQ:STI), a Dallas-based manufacturer specializing in miscellaneous electrical machinery, equipment, and supplies, has finalized employment agreements with key executive ...

Wall Street stocks ended mixed on Friday, with Nvidia climbing and Microsoft dipping, while Treasury yields declined a day ...

Society Pass Incorporated (NASDAQ:SOPA), a Nevada-based business services company with a market capitalization of $16.9 million, has amended its existing sales agreement with Ascendiant Capital ...

Eric Benevich, the Chief Commercial Officer of Neurocrine Biosciences Inc (NASDAQ:NBIX), recently disclosed significant stock transactions. According to a Form 4 filing with the Securities and ...

Robert Thomas Dechant, the Chief Executive Officer of IBEX Ltd (NASDAQ:IBEX), recently sold 5,000 common shares of the company. The sale comes as IBEX shares trade near their 52-week high of $27.83, ...

WASHINGTON—Mohammedulla Khaishgi, a director at IBEX Ltd (NASDAQ:IBEX), has recently sold a significant portion of his holdings in the company. The sale comes as IBEX shares trade near their 52-week ...

SAN DIEGO and CALGARY, AB - Oncolytics Biotech Inc. (NASDAQ: NASDAQ:ONCY) (TSX: ONC), a biotechnology firm focused on immunotherapy for cancer, has received a notification from the Nasdaq regarding ...

CEO and Chairman, Brian Chesky, recently sold a significant portion of his holdings in the company. According to a recent SEC filing, Chesky sold a total of 190,301 shares of Class A Common Stock on ...